APP and Alzheimer disease: Importantly, CDK5 expression was shown to be regulated by miR-650 in vivo using a mouse model for early onset AD: overexpression of miR-650 significantly inhibited CDK5 expression and increased the immunostaining intensity of neuronal cells in APP/PSEN1 mice.